Hoppenot Herve 4
4 · Maze Therapeutics, Inc. · Filed Oct 7, 2025
Insider Transaction Report
Form 4
Hoppenot Herve
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-06+36,000→ 36,000 totalExercise: $27.52Exp: 2035-10-05→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on November 6, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.